MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
INTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more

A.I. Advisor
published Earnings

INTS is expected to report earnings to -21 cents per share on August 18

Intensity Therapeutics INTS Stock Earnings Reports
Q2'25
Est.
$-0.22
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.95
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.04
The last earnings report on May 13 showed earnings per share of -21 cents, missing the estimate of -18 cents. With 93.34K shares outstanding, the current market capitalization sits at 7.63M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
INTS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For INTS
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com